GlassScriptPhysician profile
Bryan J Correa
NPI 1306085535
$9,799.26
in general payments reported to CMS, 2019-2025
16 companies · $3,171 in 2025
The $3,171 reported for 2025 was more than what 89% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,351 · 2020: $574 · 2021: $974 · 2022: $1,083 · 2023: $885 · 2024: $761 · 2025: $3,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,890 · Travel and Lodging: $1,840 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,890.10 |
| Travel and Lodging | $1,840.35 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,924.69 | 2019-2022 | |
| Axogen | $1,705.62 | 2024-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Stryker Corporation | $1,427.91 | 2019-2024 | Spy-Phi System |
| Motiva USA, LLC | $1,011.87 | 2025 | |
| Abbvie INC. | $894.61 | 2023-2025 | Alloderm, Natrelle Saline-Filled Breast Implants |
| Mentor Worldwide LLC | $868.42 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Merz North America, INC. | $757.20 | 2019-2022 | |
| Galderma Laboratories, L.P. | $243.81 | 2019-2025 | Dysport |
| Davol INC. | $180.07 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $157.25 | 2019-2023 | |
| Revance Therapeutics, INC. | $155.15 | 2024 | Daxxify |
| Kerecis Limited | $143.61 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Zimmer Biomet Holdings, INC. | $139.03 | 2022 | |
| Sientra, INC. | $107.25 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $49.57 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tepha INC | $33.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Correa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.